Roxanne Lagano was appointed executive vice president and chief human resources officer at Zoetis in November 2012. In this role, she is responsible for the company's worldwide human resources management and policies, colleague experience and award-winning workplace.
Ms. Lagano was given responsibility for the Global Operations and Security functions in 2020, and previously had oversight for the company’s Corporate Communications function from 2015-2019.
Prior to joining Zoetis, Ms. Lagano was senior vice president, Global Compensation, Benefits and Wellness for Pfizer. In that role, Ms. Lagano was responsible for the design and implementation of Pfizer's compensation and employee benefit programs around the globe. She was also responsible for Pfizer's wellness strategies, including the Healthy Pfizer program, and for the human resources aspects of the company's merger, acquisition and divestiture activities.
Ms. Lagano joined Pfizer in 1997 as manager, Tax Planning, after specializing in employee benefits, executive compensation and mergers and acquisitions at Schulte, Roth and Zabel, LLP, a New York law firm.
After joining Pfizer's legal division in 1999, Ms. Lagano joined Pfizer's Human Resources organization in 2000. During her time in HR for Pfizer, Ms. Lagano held various positions of increasing responsibility, including senior director of business transactions (HR) and senior director, employee benefits.
Ms. Lagano holds a bachelor’s degree from Long Island University and a Juris Doctor degree from Hofstra University School of Law.
What is Roxanne Lagano's net worth?
The estimated net worth of Roxanne Lagano is at least $2.60 million as of April 18th, 2024. Ms. Lagano owns 14,800 shares of Zoetis stock worth more than $2,599,916 as of November 21st. This net worth approximation does not reflect any other assets that Ms. Lagano may own. Learn More about Roxanne Lagano's net worth.
How old is Roxanne Lagano?
How do I contact Roxanne Lagano?
Has Roxanne Lagano been buying or selling shares of Zoetis?
Roxanne Lagano has not been actively trading shares of Zoetis over the course of the past ninety days. Most recently, Roxanne Lagano sold 923 shares of the business's stock in a transaction on Thursday, April 18th. The shares were sold at an average price of $151.17, for a transaction totalling $139,529.91. Following the completion of the sale, the executive vice president now directly owns 14,800 shares of the company's stock, valued at $2,237,316. Learn More on Roxanne Lagano's trading history.
Who are Zoetis' active insiders?
Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.
Are insiders buying or selling shares of Zoetis?
In the last twelve months, insiders at the sold shares 6 times. They sold a total of 18,632 shares worth more than $3,346,903.01. The most recent insider tranaction occured on April, 18th when EVP Roxanne Lagano sold 923 shares worth more than $139,529.91. Insiders at Zoetis own 0.2% of the company.
Learn More about insider trades at Zoetis. Information on this page was last updated on 4/18/2024.
